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doi:10.1016/j.ejvs.2010.11.019Abstract Objectives: An inflammatory process following stroke in human brains and systemic
inflammatory responses after stroke in humans have been reported by numerous investigators.
The aim of the study was to investigate if genes involved in the cyclooxygenase 2 (COX-2)
pathway are upregulated at peripheral level in patients after transient ischaemic attack
(TIA) and stroke.
Design of Study: Blood samples were obtained from two groups of patients undergoing carotid
endarterectomy. The first group included 25 patients who presented TIA or ischaemic stroke.
The second group included 35 patients who had an asymptomatic internal carotid artery
stenosis. Total RNA was isolated and the expression of Toll-like Receptor 4 (TLR4), COX-2,
membrane-associated Prostaglandin E synthase (mPGES-1), Prostaglandin E2 receptors (EP3
and EP4) was analysed by real time RT-PCR.
Results: Expression of COX-2 and TLR4 were significantly increased in symptomatic patients
(p< 0.001). Correlation analysis showed that TLR4 expression significantly correlated with
COX-2 expression (RZ 0.65; p< 0.01) in ischaemic stroke patients. This correlation was not
observed in TIA and asymptomatic patients.
Conclusions: Our results suggest that the peripheral mechanism of inflammatory injury after
stroke may be mediated by TLR4 through a COX-2-dependent pathway.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.458027674; fax: þ39 0458027180.
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TLR4 and COX-2 in Ischaemic Stroke Patients 359The risk of ipsilateral ischaemic stroke distal to a carotid
stenosis higher than 50% is between 20% and 30% during the
first 30 days following a transient ischaemic attack (TIA) or
a minor stroke.1,2 An inflammatory process following stroke
is clearly demonstrated in human brains,3 and systemic
inflammatory responses after stroke in humans have been
reported by numerous investigators.4e7 Ischaemic brain
tissue induces a response in the peripheral circulation,
including an inflammatory response, demonstrated by the
upregulation of many inflammatory molecules detected by
different methods including genome-wide messenger RNA
(mRNA) expression analysis in peripheral blood.7 Peripheral
white blood cell (WBC) count, C-reactive protein (CPR) level
and erythrocyte sedimentation rate (ESR) are increased
within 24 h after the onset of stroke and can be significantly
elevated even 3 months after the event.3,7 Prostanoids,
a family of pleiotropic lipid mediators, exert a variety of
actions in several cells and are involved in vascular inflam-
mation.8,9 In particular, prostaglandin E2 (PGE2) plasma
levels are augmented in inflammatory processes, including
atherosclerosis.9 The synthesis of PGE2 depends on the
coordinated actions of cyclooxygenase 2 (COX-2) and
membrane-bound prostaglandin E synthase-1 (mPGES-1),10
two inducible enzymes expressed in response to an inflam-
matory stimulus. PGE2 exerts its effects through specific G-
protein-coupled cell-surface receptors named Prostaglandin
E receptors (EPs), and it has been reported that EP3 and EP4
mRNA expression is increased in peripheral blood mono-
nuclear cells (PBMCs) of patientswith carotid stenosis.9 Toll-
like receptor 4 (TLR4) is a member of an evolutionarily
conserved protein family, which mediates innate immunity.
Both endogenous and exogenous ligands can activate TLR4
on cells, such as endothelial cells, vascular smooth muscle
cells, adventitial fibroblasts, dendritic cells andmacrophages.
Activated TLR4 lead to the activation of nuclear factor-kB
(NF-kB)-responsive genes, including COX-2.11 Activated tran-
scription factors mediate the secretion of pro-inflammatory
cytokines and chemokines and also induce the expression of
adhesionmolecules.Ultimately, theseprocessesmight initiate
or promote atherosclerotic lesions.12,13
Recent evidence suggests that vascular and systemic
inflammation induced by TLR4 ligands such as oxidised low-
density lipoprotein (oxLDL), pathogenic infections and heat-
shock proteins, three key players in human atherogenesis, are
mediated in part via the TLR4/NF-kB pathway.14 Upregulation
of TLR4 and downstream inflammatory factors’ expression in
monocytes from patients with acute cerebral infarction has
been reported,15 and TLR4-deficient mice after ischaemia
have significantly lower expression of COX-2 compared with
control mice,11 suggesting that increased expression of TLR4
may mediate brain damage through COX-2-dependent sig-
nalling. The aim of the study was to investigate if the genes
involved in theCOX-2pathwayareupregulatedat aperipheral
level in patients after TIA and stroke.
Materials and Methods
Study patients
Consecutive, eligible patients with internal carotid artery
stenosis undergoing carotid endarterectomy at GB RossiUniversity Hospital and Civile Maggiore Hospital (Verona)
were included in this study. Blood samples were obtained
for each patient immediately prior to endarterectomy. A
total of 25 symptomatic patients and 35 asymptomatic
patients were selected for the gene expression analysis.
The first group included patients, who presented TIA or
ischaemic stroke within the previous 23 days. The athero-
thrombotic nature of stroke was established by: (1) neu-
roradiologic aspect of a non-lacunar lesion in the carotid
artery territory; (2) evidence of ipsilateral cerebral embo-
lisation on transcranial Doppler monitoring; (3) no embolic
cardiac sources as assessed by echocardiography; and (4)
ipsilateral carotid plaque, which could benefit from carotid
endarterectomy according to North American Symptomatic
Carotid Endarterectomy Trial (NASCET).16 The second group
included patients with asymptomatic carotid plaques
causing carotid stenosis of 60% or more, not associated with
any neurological symptom.17Asymptomatic patients were
enrolled by the Vascular Surgery Department of the
University Hospital of Verona for carotid endarterectomy,
usually after a carotid Duplex scan and either carotid
magnetic resonance (MR) or computed tomography (CT) or
angiography to confirm carotid stenosis.
Clinical information and characteristics of patients,
vascular risk factors and current therapy were collected by
study neurologists. Exclusion criteria included intracerebral
haemorrhage, inflammatory pathologies and patients
ongoing non-steroidal or glucocorticoid anti-inflammatory
therapy. Two patients were excluded from the study
because of treatment with glucocorticoids. The study was
approved by the Ethical Committee of the Hospital and
informed written consent was obtained from all patients
before enrolment.
Quantitative real-time-RT-PCR
Whole blood samples rather than a specific leucocyte
subgroup, were analysed from each patient. Blood samples
(2.5 ml) were collected in PAXgene Blood RNA tubes and
total RNA was isolated using the standardised RNA Kit
(PreAnalytiX, Qiagen). The RNA isolated with this protocol
comes from all blood cells, including polymorphonuclear
(PMN) (neutrophil, basophil and eosinophil), mononuclear
cells (lymphocytes and macrophage/monocytes), platelets
and red blood cells. Total RNA was then quantified by
absorbance at A260 nm and the purity was estimated by the
ratio A260 nm/A280 nm. RNA integrity was confirmed by non-
denaturing agarose gel electrophoresis. RNA was stored at
80 C for later use. RNA samples were reverse transcribed
using a complementary DNA (cDNA) synthesis kit (Invi-
trogen), according to the supplier’s instructions.
TLR4, COX-2, mPGES-1, EP3 and EP4 gene expression
was determined by real time RT-PCR using Sybr Green I. The
specificity of the Sybr green fluorescence was tested by
plotting fluorescence as a function of temperature to
generate a melting curve of the amplicon. RT-PCR reactions
were performed in 10 ml, containing 5 ml of 2 Hot-Rescue
Real Time master mix (Diatheva), 15 ng of cDNA template
and 200 nM of forward and reverse primer. The condition
for PCR was set up as follows: a initial activation step at
95 C for 10 min, followed by 40 cycles of denaturing at
Table 1 Primers used for Real Time RT-PCR.
Genes Forward primer (50e30) Reverse primer (50e30)
TLR4 AAATTTCCGCTTCCTGGTCT TCAGCCCATATGTTTCTGGA
COX-2 TGAAACCCACTCCAAACACA AGGAGAGGTTAGAGAAGGCT
mPGES-1 CATCAAGARGTACGTGGT GGAGTAGACGAAGCCC
EP3 GTGCTGTCGGTCTGCTG CTTTCTGCTTCTCCGTGTG
EP4 CATCTGCTCCATCCCGCT GGATGGCCTGCAAATCTGG
GAPDH TCCTGTTCGACAGTCAGC ACGACCAAATCCGTTGAC
TBP TGTATCCACAGTGAATCTTGG ATGATTACCGCAGCAAACC
360 S. Ferronato et al.95 C for 15 s, annealing at 60 C for 15 s and extension at
72 C for 20 s. Amplifications were performed using an
Eppendorf Mastercycler realplex. Each sample was
amplified in triplicate and, for each procedure, negative
controls without template were included. Potential
genomic DNA contamination was excluded by using intron-
encompassing primers and DNase treatment of the RNA
samples. Amplification efficiency was calculated for each
assay by a standard curve made out of four serial dilutions
of a pool of cDNA of symptomatic and asymptomatic
patients. The experiment was conducted twice. Glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) and TATA
box-binding protein (TBP) genes were chosen as the
endogenous controls to normalise target genes. Normal-
isation of target gene-expression levels was performed to
compensate for intra- and inter-kinetic Real Time RT-PCR
variations (sample-to-sample cell concentration and run-to-
run variations). Primers used for amplification are
described in Table 1. The comparative quantification of
gene expression was determined using Pfaffl’s efficiency
corrected calculation. The Pfaffl mathematical model is
based on the correction for exact PCR efficiencies and the
mean crossing point deviation between sample group(s) and
control group(s). This method takes into account the fact
that small efficiency differences between target andTable 2 Characteristics of the Study Patients. There were no sig
Variable
Age, y (mean)
Sex
Male (%)
Female (%)
TIA patients (%)
Stroke patients (%)
Risk factors
Hypertension (%)
Diabetes (%)
Smoking (%)
Dyslipidemia (%)
NSAID or glucocorticoid treatment (%)
Acetylsalicylic acid (%)
Statin (%)
ACE-inhibitor (%)
NSAID, non-steroidal anti-inflammatory drug; TIA, transient ischaemicreference gene amplifications generate a false expression
ratio, and the researcher over- or underestimates the ‘real’
initial mRNA amount.
Statistical analysis
The ShapiroeWilk test was applied to check for normal
distribution. Statistical analysis was done with logarithmi-
cally transformed values when they were not normally
distributed. Differences in gene expression were analysed
by Student’s t test. We tested the significance of the
Pearson correlation coefficient to evaluate the relations
between the target genes. Significance was assumed with
a p value of 0.05. For risk factors and drug therapy, vari-
ables were compared by the use of Fisher’s exact test.
Results
Patient demographics
Demographic and clinical data of subjects are summarised
in Table 2. The asymptomatic group was represented by 23
men and 12 women with a median age of 72.6 years (range
50e87) while the symptomatic group was represented by 23nificant differences between groups (p> 0.05 for all groups).
Asymptomatic Symptomatic
NZ 35 NZ 25
72.6 8.1 70.8 9.5
23 (66) 23 (92)
12 (34) 2 (8)
0 8 (32)
0 17 (68)
30 (86) 17 (68)
6 (17) 6 (24)
16 (46) 12 (48)
26 (74) 12 (48)
0 0
23 (66) 19 (76)
19 (54) 13 (52)
20 (57) 12 (48)
attack.
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50e85). Fisher’s exact test showed no significant differ-
ences between sex, cardiovascular risk factors and the
current drug therapy between the two groups of patients.
TLR4, COX-2, mPGES-1, EP3 and EP4 gene
expression
Real Time RT-PCR was used to determine gene expression
on total RNA from peripheral blood. A significant increase
of COX-2 and TLR4 gene expression was observed in symp-
tomatic compared with asymptomatic patients (1.51 0.36
vs. 0.81 0.63; p< 0.001; 1.54 0.94 vs. 0.84 0.56;
p< 0.001, respectively) (Fig. 1(A) and (B)). The expression
of both genes was independent of the time from ischaemicFigure 1 Gene expression of COX-2 (A), TLR4 (B) and EP4 (C)
in symptomatic and asymptomatic patients. Real time RT-PCR
was performed on total RNA extracted from whole peripheral
blood from 25 symptomatic (stroke and TIA) patients and 35
asymptomatic patients. Gene expression was normalised to the
GAPDH and TBP housekeeping genes. Bars indicate mean values
of each group. P values are indicated in each graph.event at which blood samples were collected. (Pearson
correlation for COX-2, TLR4 and EP4: RZ0.04, 0.05 and
0.21, respectively; figures not shown). The EP4 gene did not
show differential expression between symptomatic and
asymptomatic patients (Fig. 1(C)). The method was not
sensitive enough to consistently detect mPGES-1 and EP3
gene expression, even using different sets of primers and
amplification conditions (data not shown).
Correlation between genes analysed
Stratifying the symptomatic group in TIA and stroke, we
could observe a correlation between TLR4 and COX-2 gene
expression (RZ 0.65; p< 0.01) (Fig. 2). This correlation
was not observed in TIA (RZ 0.01; p> 0.05) and asymp-
tomatic patients (RZ 0.03; p> 0.05) (data not shown).
Discussion
Immediately after cerebral infarction, intense peripheral
inflammatory reactions may occur, including activation of
inflammatory cells and production of high levels of inflam-
matory cytokines. Because of injury to the bloodebrain
barrier after cerebral infarction, activated mononuclear
macrophages enter the brain tissue, causing inflammatory
and intensified cerebral injury.15 Previous studies have
demonstrated that markers of inflammation including
interleukins (IL1, IL-8, IL-10 and IL-17), interferon gamma
and macrophage inflammatory protein (MIP) mRNAs are
elevated in PBMCs in patients and animals with ischaemic
stroke. Similarly, leucocyte proteinases, interleukins,
matrix metalloproteinases (MMPs) and integrins are
elevated in patients after both acute stroke and TIAs,6 and
can be significantly elevated even 3months after the event.5
The first studies of whole genome expression in human blood
after ischaemic stroke were reported by Tang et al. and
Moore et al.6,18 They provide the proof-of-principle studies
in humans that changes of gene expression occur at very
early times in the peripheral blood of patients after
ischaemic stroke. Peripheral blood has become an attractive
prime tissue for biomarker detection because of its critical
role in immune response, metabolism, communication with
cells and the extracellular matrix in almost all tissues and
organs in the human body. The dynamic and interactiveFigure 2 Association between TLR4 and COX-2 mRNA values in
peripheral blood of 17 stroke patients. TLR4 and COX-2 was
measured by real-time-RT-PCR and normalised to GAPDH and TBP.
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changes occurring within the body, such as changes in
association with a disease process or in response to an injury,
may leave ‘footprints’ in blood. Therefore, transcriptional
profiling fromwhole blood cells might provide an alternative
to tissue biopsy in the search for biomarker genes of
cardiovascular disease.19 RNA extracted from peripheral
blood cells is easily accessible and can be routinely used for
diagnostic laboratory analysis, and, thus, it is a good
resource for additional tests that might define the extent of
vascular artery disease. It must be remembered that
detection of the presence of an mRNA provides no informa-
tion on whether that mRNA will be translated into a protein.
Immunohistochemistry, Western blotting or other protein-
quantification methods would be necessary to determine if
protein levels correspond with mRNA expression.
In this study, we provide evidence of an augmented TLR4
and COX-2 gene expression in peripheral whole blood of
patients, who have had a stroke or TIA, compared with
patients with asymptomatic stenosis. Upregulation of TLR4
has been previously observed15 on peripheral blood mono-
cytes from patients with acute cerebral infarct within 24 h
after the onset of the symptoms as compared with TIA and
healthy control groups. An increase of COX-2 expression in
the inflammatory region of atherosclerotic plaques,9,20 and
in PBMCs of patients with carotid stenosis as compared with
healthy controls9 have been reported. Our results show an
upregulation of TLR4 and COX-2 in TIA and stroke patients
in peripheral blood up to 23 days (10.9 7.2 days) after the
ischaemic event. Time from appearance of the symptoms to
blood collecting ranged from 0 to 23 days. No correlation
was found between gene expression level and time from
stroke/TIA to blood collection. Analysis of whole blood RNA
expression does not exclude the possibility that percent-
ages of specific blood subtypes differ between each
sample, and hence that different numbers of subtypes are
responsible for the observed effect. On the other hand, the
isolation process of subtypes of leucocytes could, in itself,
affect the gene expression pattern.
To the best of our knowledge, this is the first time that
differential expression of TLR4 and COX-2 has been
demonstrated in whole peripheral blood of symptomatic
carotid patients compared with patients with asymptom-
atic plaques. To determine if these changes represent
a result of stroke or a contribution to plaque destabilisation
as a precursor to stroke, we have ongoing gene-expression
studies on whole peripheral blood of cardioembolic stroke
patients and on vulnerable and stable plaques. A positive
correlation between TLR4 and COX-2 expression was
observed in patients who presented ischaemic stroke,
suggesting that TLR4 may participate in the peripheral
inflammatory mechanism after stroke through a COX-2-
dependent pathway. This hypothesis is in part supported by
studies on TLR4-deficient mice suggesting that brain
damage may be mediated by an increased expression of
TLR4 through a COX-2-dependent signalling.11 Further in
vivo animal studies on peripheral blood and in vitro cell
culture experiments are necessary to confirm these obser-
vations. The correlation between TLR4 and COX-2 was not
observed in TIA patients. The TIA sample size is rather small
and this may significantly compromise the statistical power;
hence, the lack of correlation between genes observed maybe due because the statistic power is not greater enough to
identify the significance. However, recent histological
studies in carotid plaques have reported that inflammatory
components in TIA are different from those in stroke pla-
ques suggesting that molecular mechanisms underlying TIA
and stroke are different,21 with TIA a more chronic and
stroke a more acute process.3 The analysis of COX-2
downstream-related genes demonstrated little or no
expression of mPGES and EP3, and no differential expres-
sion of EP4. This fact suggests that stimulation of these
downstream COX-2 related genes, as seen in the shoulder
region of human atherosclerotic plaques,9 or in rat brain
after cerebral ischaemia,22,23 may occur after activated
monocytes have infiltrated the target tissue. In conclusion,
the present study indicates that upregulation of TLR4
expression on whole blood from symptomatic patients
positively correlates with the upregulated expression of the
pro-inflammatory gene COX-2. These results suggest that
TLR4 may participate in peripheral mechanisms of inflam-
matory injury after stroke through a COX-2-dependent
pathway, and support other studies that encourage the
development of TLR4 inhibitors as an alternative to COX-2
inhibitors (coxibs) in the treatment of the acute phase of
ischaemic stroke.24,25
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